Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Liver Cancer Screening Guidelines for High-Risk Individuals

High-Risk Populations Requiring Screening

  • The American Association for the Study of Liver Diseases recommends that all patients with cirrhosis should be offered surveillance for hepatocellular carcinoma (HCC) unless they have a relatively high risk of death from non-HCC causes or are ineligible for curative treatment 1, 3
  • Patients with chronic hepatitis B and specific risk factors, such as Asian men over 40 years, Asian women over 50 years, African/North American blacks, and those with a family history of HCC, should be screened for HCC 2, 4
  • Non-cirrhotic patients with chronic hepatitis C and advanced liver fibrosis (F3) should be considered for screening 2, 4
  • The European Association for the Study of the Liver recommends ultrasound examination of the liver every 6 months as the primary screening method for HCC in high-risk individuals 1, 2, 4
  • The combined use of ultrasound with alpha-fetoprotein (AFP) testing increases sensitivity while decreasing specificity and is a reasonable option 1, 6

Diagnostic Criteria and Follow-up

  • Non-invasive diagnosis of HCC should be based on the LI-RADS CT/MR v2018 or the LI-RADS CEUS v2017 criteria 1
  • Typical hallmarks include arterial phase hyperenhancement with washout appearance in portal venous or delayed phases 1, 7
  • For nodules ≥1 cm, first-line imaging with multiphasic contrast-enhanced CT or MRI with extracellular contrast agent or hepatocyte-specific contrast agent is recommended 1, 7

Special Considerations

  • Standard surveillance interval is every 6 months for all high-risk groups 1, 2, 4
  • Some Asian guidelines recommend more frequent surveillance (every 3-4 months) for extremely high-risk groups such as patients with HBV/HCV-related cirrhosis 8, 9